M
10b5-1 Plan
$ Value
$5K
Shares
200
Price
$25
Filed
Nov 3
Insider
Name
Gheuens Sarah
Title
Chief Medical Officer
CIK
0001881190
Roles
Officer
Transaction Details
Transaction Date
2025-10-30
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
61,927
Footnotes
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. | This option was originally granted on March 1, 2023 for the purchase of 44,000 shares of common stock. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter.
Filing Info
Gheuens Sarah's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-02 | AGIO | M | $0 |
| 2026-04-02 | AGIO | ▼ | $102K |
| 2026-04-02 | AGIO | M | $0 |
| 2025-12-30 | AGIO | M | $0 |
| 2025-12-30 | AGIO | ▼ | $79K |
| 2025-12-30 | AGIO | M | $0 |
| 2025-11-11 | AGIO | M | $61K |
| 2025-11-11 | AGIO | ▼ | $107K |
| 2025-11-11 | AGIO | M | $0 |
| 2025-10-30 | AGIO | M | $5K |
Other Insiders at AGIO (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Goff Brian
Chief Executive Officer
|
— | $662K | 2026-04-02 |
|
Jones Cecilia
Chief Financial Officer
|
— | $109K | 2026-04-02 |
|
Gheuens Sarah
Chief Medical Officer
|
— | $102K | 2026-04-02 |
|
Burns James William
Chief Legal Officer
|
— | $114K | 2026-04-02 |
|
Milanova Tsveta
Chief Commercial Officer
|
— | $113K | 2026-04-02 |
|
Viswanadhan Krishnan
Chief Corp Dev & Strategy
|
— | $103K | 2026-04-02 |